Author

C. Molina-Lopez

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

L. Hurtado-Navarro· 2 shared P. Pelegrin· 2 shared A. Baroja-Mazo· 1 shared A. Penin-Franch· 1 shared D. Angosto-Bazarra· 1 shared J. Garcia-Villalba· 1 shared J. Soubhye· 1 shared J.-M. Ruysschaert· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

L. Hurtado-Navarro

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Soluble P2X7 receptor is elevated in the plasma of COVID-19 patients and correlates with disease severity

J. Garcia-Villalba, L. Hurtado-Navarro, A. Penin-Franch, C. Molina-Lopez, L. Martinez-Alarcon, D. Angosto-Bazarra, A. Baroja-Mazo, P. Pelegrin

This study finds elevated soluble P2X7 receptor in COVID-19 patient plasma, correlating with disease severity but not IL-18 levels.

bioRxiv · Mar 4, 2022 · PreprintImmunology

Ornithine Lipid is a Partial TLR4 Agonist and NLRP3 Activator

M. Pizzuto, L. Hurtado-Navarro, C. Molina-Lopez, J. Soubhye, M. Gelbcke, S. Rodriguez-Lopez, J.-M. Ruysschaert, K. Schroder, P. Pelegrin

This study identifies ornithine lipid as a partial TLR4 agonist and NLRP3 activator, showing it can replace LPS in phosphate-depleted environments to trigger inflammation.

bioRxiv · Jan 28, 2022Immunology